NCT02232061 Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks Status COMPLETED Phase PHASE4
NCT02229136 Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus Status COMPLETED Phase PHASE2
NCT02228681 Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02228096 Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients Status COMPLETED Phase PHASE2
NCT02226120 Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction Status COMPLETED Phase PHASE3
NCT02221505 Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT02220855 A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas Status COMPLETED Phase PHASE2
NCT02217410 CCFZ533X2201 - PoC Study in de Novo Renal Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT02213042 Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT02205398 Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy Status TERMINATED Phase PHASE1
NCT02204553 Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma Status NO_LONGER_AVAILABLE Phase N/A
NCT02202616 Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study) Status COMPLETED Phase PHASE4
NCT02201290 A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Status COMPLETED Phase PHASE3
NCT02195973 Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer Status COMPLETED Phase PHASE1
NCT02194803 Observation of Treatment Patterns With Lucentis in Approved Indications Status COMPLETED Phase N/A
NCT02190604 Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients Status TERMINATED Phase PHASE1/PHASE2
NCT02189174 Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies Status TERMINATED Phase PHASE1